Sign In

Login

Password

Forgot Password ? Sign Up

Melioidoosi (Finnish Wikipedia)

Analysis of information sources in references of the Wikipedia article "Melioidoosi" in Finnish language version.

refsWebsite
Global rank Finnish rank
36doi.org
2nd place
10th place
35nih.gov
4th place
12th place
2web.archive.org
1st place
1st place
2cdc.gov
218th place
595th place
1ajtmh.org
low place
low place
1nih.go.jp
low place
low place
1google.co.uk
504th place
1,178th place
1jpgmonline.com
low place
low place
1army.mil
249th place
911th place

ajtmh.org

  • Vuddhakul V, Tharavichitkul P, Na-Ngam N, et al: Epidemiology of Burkholderia pseudomallei in Thailand. Am. J. Trop. Med. Hyg., 1999, 60. vsk, nro 3, s. 458–61. PubMed:10466977 Artikkelin verkkoversio.

army.mil

usamriid.army.mil

  • Woods JB (ed.): USAMRIID's Medical Management of Biological Casualties Handbook, s. 67. 6th ed. painos. Fort Detrick, Maryland: U.S. Army Medical Institute of Infectious Diseases, 2005. Teoksen verkkoversio (PDF). (Arkistoitu – Internet Archive)

cdc.gov

doi.org

dx.doi.org

  • White NJ: Melioidosis. Lancet, 2003, 361. vsk, s. 1715–22. doi:10.1016/S0140-6736(03)13374-0
  • Cheng AC, Currie BJ: Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev, 2005, 18. vsk, s. 383–416. PubMed:15831829 doi:10.1128/CMR.18.2.383-416.2005
  • Struelens MJ, Mondol G, Bennish M, Dance DAB: Melioidosis in Bangladesh: a case report. Trans R Soc Trop Med Hygiene, 1998, 82. vsk, s. 777–78. doi:10.1016/0035-9203(88)90234-9
  • Dance DAB, Smith MD, Aucken HM, Pitt TL: Imported melioidosis in England and Wales. Lancet, 1999, 353. vsk, s. 208. doi:10.1016/S0140-6736(05)77217-2
  • Sprague LD, Neubauer H: Melioidosis in Animals: A review on epizootiology, diagnosis and clinical presentation. J Vet Med B, 2004, 51. vsk, s. 305–20. doi:10.1111/j.1439-0450.2004.00797.x
  • Suputtamongkol Y, Chaowagul W, Chetchotisakd P, et al.: Risk factors for melioidosis and bacteremic melioidosis. Clin Infect Dis, 1999, 29. vsk, s. 408–13. doi:10.1086/520223
  • Suputtamongkol Y, Hall AJ, Dance DAB, et al.: The epidemiology of melioidosis in Ubon Ratchatani, Northeast Thailand. Int J Epidemiol, 1994, 23. vsk, s. 1082–89. PubMed:7860160 doi:10.1093/ije/23.5.1082
  • Liu Y, Loh JP, Aw LT, Yap EPH, Lee MA, Ooi EE: Rapid molecular typing of Burkholderia pseudomallei, isolated in an outbreak of melioidosis in Singapore in 2004, based on variable-number tandem repeats. Trans Roy Soc Trop Med Hyg, 2006, 100. vsk, s. 687–92. doi:10.1016/j.trstmh.2005.08.017
  • Sam I-C, Puthucheary SD: Melioidosis and rainfall in Kuala Lumpur, Malaysia. J Infect, 2007, 54. vsk, nro 5, s. 519–20. doi:10.1016/j.jinf.2006.07.007
  • Ngauy V, Lemeshev Y, Sadkowski L, Crawford G: Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microb, 2005, 43. vsk, nro 2, s. 970–2. PubMed:15695721 doi:10.1128/JCM.43.2.970-972.2005
  • Apisarnthanarak A, Apisarnthanarak P, Mundy LM.: Computer tomography characteristics of Burkholderia pseudomallei liver abscess. Clin Infect Dis, 2006, 42. vsk, s. 989–93. doi:10.1086/501017
  • Chlebicki, MP: Six cases of suppurative lymphadenitis caused by Burkholderia pseudomallei infection. Trans R Soc Trop Med Hyg, 2006, 100. vsk, nro 8, s. 798–801. PubMed:16542691 doi:10.1016/j.trstmh.2005.10.004
  • Falade OO, Antonarakis ES, Kaul DR, Saint S, Murphy PA: Clinical problem-solving. Beware of first impressions. N Engl J Med, 2008, 359. vsk, s. 628–634. doi:10.1056/NEJMcps0708803
  • Wuthiekanun V, Suputtamongkol Y, Simpson AJH, Kanaphun P, White NJ: Value of throat swab in the diagnosis of melioidosis. J Clin Microbiol, 2001, 39. vsk, s. 3801–02. PubMed:11574624 doi:10.1128/JCM.39.10.3801-3802.2001
  • Limmathurotsakul D,Wuthiekanun V,Chierakul W, et al.: Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microb, 2005, 43. vsk, nro 5, s. 2274–76. PubMed:15872255 doi:10.1128/JCM.43.5.2274-2276.2005
  • Dance DA, White NJ, Suputtamongkol Y, Wattanagoon Y, Wuthiekanun V, Chaowagul W: The use of bone marrow culture for the diagnosis of melioidosis. Trans R Soc Trop Med Hyg, 1990, 84. vsk, nro 4, s. 585–7. PubMed:2091358 doi:10.1016/0035-9203(90)90050-O
  • Francis A, Aiyar S, Yean C, Naing L, Ravichandran M: An improved selective and differential medium for the isolation of Burkholderia pseudomallei from clinical specimens. Diagn Microbiol Infect Dis, 2006, 55. vsk, nro 2, s. 95–99. doi:10.1016/j.diagmicrobio.2005.11.008
  • White NJ, Dance DA, Chaowagul W, et al.: Halving of mortality of severe melioidosis by ceftazidime. Lancet, 1989, 2. vsk, nro 8665, s. 697–701. PubMed:2570956 doi:10.1016/S0140-6736(89)90768-X
  • Cheng AC, Fisher DA, Anstey NM, et al.: Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother, 2004, 48. vsk, nro 5, s. 1763–65. PubMed:15105132 doi:10.1128/AAC.48.5.1763-1765.2004
  • Simpson AJ, Suputtamongkol Y, Smith MD, et al.: Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis, 1999, 29. vsk, nro 2, s. 381–7. PubMed:10476746 doi:10.1086/520219
  • Chetchotisakd P, Porramatikul S, Mootsikapun P, Anunnatsiri S, Thinkhamrop B: Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Clin Infect Dis, 2001, 33. vsk, s. 29–3. PubMed:11389491 doi:10.1086/320878
  • Dance DA, Wuthiekanun V, White NJ, Chaowagul W: Antibiotic resistance in Pseudomonas pseudomallei. Lancet, 1988, 1. vsk, nro 8592, s. 994–5. PubMed:2896855 doi:10.1016/S0140-6736(88)91810-7
  • Currie BJ, Fisher DA, Howard DM, et al.: Endemic melioidosis in tropical Northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis, 2000, 31. vsk, s. 981–86. PubMed:11049266 doi:10.1086/318116
  • Infection, 2008. doi:10.1007/s15010-008-7324-8
  • Cheng AC, Limmathurotsakul D, Chierakul W, et al.: A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis, 2007, 45. vsk, nro 3, s. 308–14. PubMed:17599307 doi:10.1086/519261
  • Chierakul W, Anunnatsiri S, Short JM, et al.: Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis, 2005, 41. vsk, nro 8, s. 1105–13. PubMed:16163628 doi:10.1086/444456
  • Chierakul W, Anunnatsiri S, Chaowagul W, Peacock SJ, Chetchotisakd P, Day NP: Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a tong-term outcome benefit. Clin Infect Dis, 2007, 45. vsk, nro 4, s. 521–3. PubMed:17638209 doi:10.1086/520010
  • Chaowagul W, Simpson AJ, Suputtamongkol Y, et al.: A comparison of chloramphenicol, trimethoprim-sulfamethoxazole, and doxycycline with doxycycline alone as maintenance therapy for melioidosis. Clin Infect Dis, 1999, 29. vsk, s. 375–80. doi:10.1086/520218
  • Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DA, White NJ.: A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg, 1995, 89. vsk, s. 546–9. PubMed:8560537 doi:10.1016/0035-9203(95)90104-3
  • Chaowagul W, Supputtamongkul Y, Smith MD, White NJ.: Oral fluoroquinolones for maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg, 1997, 91. vsk, s. 599–601. doi:10.1016/S0035-9203(97)90044-4
  • Limmathurotsakul D, Chaowagul W, Chierakul Wirongrong, et al.: Risk factors for recurrent melioidosis in Northeastern Thailand. Clin Infect Dis, 2006, 43. vsk, s. 979–86. PubMed:16983608 doi:10.1086/507632
  • Dance DA, Wuthiekanun V, Chaowagul W, White NJ: Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother, 1989, 24. vsk, s. 311–6. PubMed:2681117 doi:10.1093/jac/24.3.311
  • Dance DA, Wuthiekanun V, Chaowagul W, White NJ: Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother, 1989, 24. vsk, s. 311–6. PubMed:2681117 doi:10.1093/jac/24.3.311
  • Warner JM, Pelowa DB, Currie BJ, Hirst RG: Melioidosis in a rural community of Western Province, Papua New Guinea. Trans R Soc Trop Med Hyg, 2007, 101. vsk, s. 809. PubMed:17499321 doi:10.1016/j.trstmh.2007.02.024
  • Maharjan B, Chantratita N, Vesaratchavest M, et al.: Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol, 2005, 43. vsk, nro 12, s. 6032–4. PubMed:16333094 doi:10.1128/JCM.43.12.6032-6034.2005
  • Sivalingam SP, Sim SH, Jasper LC, et al.: Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. J Antimicrob Chemother, 2008, 61. vsk, nro 3, s. 674–8. PubMed:18192684 doi:10.1093/jac/dkm527

google.co.uk

scholar.google.co.uk

jpgmonline.com

nih.go.jp

  • Chen YS, Chen SC, Wu TR, Kao CM, Chen YL: Seroprevalence of anti-flagellin antibody against Burkholderia pseudomallei in Taiwan. Jpn. J. Infect. Dis., 2004, 57. vsk, nro 5, s. 224–5. PubMed:15507783 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Cheng AC, Currie BJ: Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev, 2005, 18. vsk, s. 383–416. PubMed:15831829 doi:10.1128/CMR.18.2.383-416.2005
  • Ko WC: Melioidosis outbreak after typhoon, southern Taiwan. Emerg Infect Dis, 2007, 13. vsk, nro 6, s. 896–8. PubMed:17553230
  • Vuddhakul V, Tharavichitkul P, Na-Ngam N, et al: Epidemiology of Burkholderia pseudomallei in Thailand. Am. J. Trop. Med. Hyg., 1999, 60. vsk, nro 3, s. 458–61. PubMed:10466977 Artikkelin verkkoversio.
  • Kanai K, Dejsirilert S: Pseudomonas pseudomallei and melioidosis, with special reference to the status in Thailand. Jpn. J. Med. Sci. Biol., 1988, 41. vsk, nro 4, s. 123–57. PubMed:3075004
  • Yang S, Tong S, Mo C, et al: Prevalence of human melioidosis on Hainan Island in China. Microbiol. Immunol., 1998, 42. vsk, nro 9, s. 651–4. PubMed:9802565
  • Chen YS, Chen SC, Wu TR, Kao CM, Chen YL: Seroprevalence of anti-flagellin antibody against Burkholderia pseudomallei in Taiwan. Jpn. J. Infect. Dis., 2004, 57. vsk, nro 5, s. 224–5. PubMed:15507783 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
  • Suputtamongkol Y, Hall AJ, Dance DAB, et al.: The epidemiology of melioidosis in Ubon Ratchatani, Northeast Thailand. Int J Epidemiol, 1994, 23. vsk, s. 1082–89. PubMed:7860160 doi:10.1093/ije/23.5.1082
  • Currie BJ, Jacups SP: Intensity of rainfall and severity of melioidosis, Australia. Emerging Infect. Dis., 2003, 9. vsk, nro 12, s. 1538–42. PubMed:14720392 Artikkelin verkkoversio. (– Scholar search)
  • Ngauy V, Lemeshev Y, Sadkowski L, Crawford G: Cutaneous melioidosis in a man who was taken as a prisoner of war by the Japanese during World War II. J Clin Microb, 2005, 43. vsk, nro 2, s. 970–2. PubMed:15695721 doi:10.1128/JCM.43.2.970-972.2005
  • Dance DA, Davis TM, Wattanagoon Y, et al.: Acute suppurative parotitis caused by Pseudomonas pseudomallei in children. J Infect Dis, 1989, 159. vsk, nro 4, s. 654–60. PubMed:2926159
  • Raja, NS: Melioidosis: an emerging infectious disease. Journal of Postgraduate Medicine, 2005, 51. vsk, nro 2, s. 140–45. PubMed:16006713 Artikkelin verkkoversio.
  • Chlebicki, MP: Six cases of suppurative lymphadenitis caused by Burkholderia pseudomallei infection. Trans R Soc Trop Med Hyg, 2006, 100. vsk, nro 8, s. 798–801. PubMed:16542691 doi:10.1016/j.trstmh.2005.10.004
  • Wuthiekanun V, Suputtamongkol Y, Simpson AJH, Kanaphun P, White NJ: Value of throat swab in the diagnosis of melioidosis. J Clin Microbiol, 2001, 39. vsk, s. 3801–02. PubMed:11574624 doi:10.1128/JCM.39.10.3801-3802.2001
  • Limmathurotsakul D,Wuthiekanun V,Chierakul W, et al.: Role and significance of quantitative urine cultures in diagnosis of melioidosis. J Clin Microb, 2005, 43. vsk, nro 5, s. 2274–76. PubMed:15872255 doi:10.1128/JCM.43.5.2274-2276.2005
  • Dance DA, White NJ, Suputtamongkol Y, Wattanagoon Y, Wuthiekanun V, Chaowagul W: The use of bone marrow culture for the diagnosis of melioidosis. Trans R Soc Trop Med Hyg, 1990, 84. vsk, nro 4, s. 585–7. PubMed:2091358 doi:10.1016/0035-9203(90)90050-O
  • Muttarak M, Peh WC, Euathrongchit J, Lin SE, Tan AG, Lerttumnongtum P, Sivasomboon C: Spectrum of imaging findings in melioidosis. Br J Radiol, 2008. PubMed:19098086
  • White NJ, Dance DA, Chaowagul W, et al.: Halving of mortality of severe melioidosis by ceftazidime. Lancet, 1989, 2. vsk, nro 8665, s. 697–701. PubMed:2570956 doi:10.1016/S0140-6736(89)90768-X
  • Cheng AC, Fisher DA, Anstey NM, et al.: Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother, 2004, 48. vsk, nro 5, s. 1763–65. PubMed:15105132 doi:10.1128/AAC.48.5.1763-1765.2004
  • Simpson AJ, Suputtamongkol Y, Smith MD, et al.: Comparison of imipenem and ceftazidime as therapy for severe melioidosis. Clin Infect Dis, 1999, 29. vsk, nro 2, s. 381–7. PubMed:10476746 doi:10.1086/520219
  • Chetchotisakd P, Porramatikul S, Mootsikapun P, Anunnatsiri S, Thinkhamrop B: Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Clin Infect Dis, 2001, 33. vsk, s. 29–3. PubMed:11389491 doi:10.1086/320878
  • Dance DA, Wuthiekanun V, White NJ, Chaowagul W: Antibiotic resistance in Pseudomonas pseudomallei. Lancet, 1988, 1. vsk, nro 8592, s. 994–5. PubMed:2896855 doi:10.1016/S0140-6736(88)91810-7
  • Currie BJ, Fisher DA, Howard DM, et al.: Endemic melioidosis in tropical Northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis, 2000, 31. vsk, s. 981–86. PubMed:11049266 doi:10.1086/318116
  • Cheng AC, Limmathurotsakul D, Chierakul W, et al.: A randomized controlled trial of granulocyte colony-stimulating factor for the treatment of severe sepsis due to melioidosis in Thailand. Clin Infect Dis, 2007, 45. vsk, nro 3, s. 308–14. PubMed:17599307 doi:10.1086/519261
  • Chierakul W, Anunnatsiri S, Short JM, et al.: Two randomized controlled trials of ceftazidime alone versus ceftazidime in combination with trimethoprim-sulfamethoxazole for the treatment of severe melioidosis. Clin Infect Dis, 2005, 41. vsk, nro 8, s. 1105–13. PubMed:16163628 doi:10.1086/444456
  • Chierakul W, Anunnatsiri S, Chaowagul W, Peacock SJ, Chetchotisakd P, Day NP: Addition of trimethoprim-sulfamethoxazole to ceftazidime during parenteral treatment of melioidosis is not associated with a tong-term outcome benefit. Clin Infect Dis, 2007, 45. vsk, nro 4, s. 521–3. PubMed:17638209 doi:10.1086/520010
  • Rajchanuvong A, Chaowagul W, Suputtamongkol Y, Smith MD, Dance DA, White NJ.: A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg, 1995, 89. vsk, s. 546–9. PubMed:8560537 doi:10.1016/0035-9203(95)90104-3
  • Cheng AC, Chierakul W, Chaowagul W, et al.: Consensus guidelines for dosing of amoxicillin-clavulanate in melioidosis. Am J Trop Med Hyg, 2008, 78. vsk, nro 2, s. 208–9. PubMed:18256414
  • Limmathurotsakul D, Chaowagul W, Chierakul Wirongrong, et al.: Risk factors for recurrent melioidosis in Northeastern Thailand. Clin Infect Dis, 2006, 43. vsk, s. 979–86. PubMed:16983608 doi:10.1086/507632
  • Dance DA, Wuthiekanun V, Chaowagul W, White NJ: Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother, 1989, 24. vsk, s. 311–6. PubMed:2681117 doi:10.1093/jac/24.3.311
  • Dance DA, Wuthiekanun V, Chaowagul W, White NJ: Interactions in vitro between agents used to treat melioidosis. J Antimicrob Chemother, 1989, 24. vsk, s. 311–6. PubMed:2681117 doi:10.1093/jac/24.3.311
  • Warner JM, Pelowa DB, Currie BJ, Hirst RG: Melioidosis in a rural community of Western Province, Papua New Guinea. Trans R Soc Trop Med Hyg, 2007, 101. vsk, s. 809. PubMed:17499321 doi:10.1016/j.trstmh.2007.02.024
  • Maharjan B, Chantratita N, Vesaratchavest M, et al.: Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol, 2005, 43. vsk, nro 12, s. 6032–4. PubMed:16333094 doi:10.1128/JCM.43.12.6032-6034.2005
  • Chaowagul W, Suputtamongkol Y, Dance DA, Rajchanuvong A, Pattara-arechachai J, White NJ: Relapse in melioidosis: incidence and risk factors. J Infect Dis, 1993, 168. vsk, s. 1181–85. PubMed:8228352
  • Sivalingam SP, Sim SH, Jasper LC, et al.: Pre- and post-exposure prophylaxis of experimental Burkholderia pseudomallei infection with doxycycline, amoxicillin/clavulanic acid and co-trimoxazole. J Antimicrob Chemother, 2008, 61. vsk, nro 3, s. 674–8. PubMed:18192684 doi:10.1093/jac/dkm527
  • Centers for Disease Control and Prevention: Laboratory exposure to Burkholderia pseudomallei—Los Angeles, California, 2003. MMWR Morb Mortal Wkly Rep, 2004, 53. vsk, nro 42, s. 988–90. PubMed:15514581

web.archive.org

  • Chen YS, Chen SC, Wu TR, Kao CM, Chen YL: Seroprevalence of anti-flagellin antibody against Burkholderia pseudomallei in Taiwan. Jpn. J. Infect. Dis., 2004, 57. vsk, nro 5, s. 224–5. PubMed:15507783 Artikkelin verkkoversio. (Arkistoitu – Internet Archive)
  • Woods JB (ed.): USAMRIID's Medical Management of Biological Casualties Handbook, s. 67. 6th ed. painos. Fort Detrick, Maryland: U.S. Army Medical Institute of Infectious Diseases, 2005. Teoksen verkkoversio (PDF). (Arkistoitu – Internet Archive)